ArticleLiver cancer2022

Combination Immunotherapy with Anti-PD-1/PD-L1 Antibody plus Anti-VEGF Antibody May Promote Cytotoxic T Lymphocyte Infiltration in Hepatocellular Carcinoma, Including in the Noninflamed Subclass.

Masatoshi KudoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.